Dyslipidaemia and coronary heart disease: nature vs nurture.
In order to enhance health care for patients with coronary heart disease (CHD), genetic markers of susceptibility could be incorporated into a formula for risk evaluation that includes traditional factors. Preventive measures could then be targeted towards 'high-risk' subjects. But can the genetic component be dissected from the environmental component in an intermediate CHD phenotype, such as plasma lipoproteins.
Hegele
R A
RA
Department of Medicine, University of Toronto, Ontario, Canada.
D003327:Coronary Disease / Q000209:etiology*; D004777:Environment; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000235:genetics* / Q000517:prevention & control; D008074:Lipoproteins / Q000097:blood / Q000235:genetics; D010641:Phenotype; D012307:Risk Factors
D005819:Genetic Markers; D008074:Lipoproteins